Medicare Will Lead To National Formulary, Smaller Firms – Novartis Exec
Executive Summary
The Medicare prescription drug benefit will ultimately evolve into a de facto national formulary, Novartis VP-Business Development & Licensing Gary Cupit predicted
You may also be interested in...
Medicare Rx Cards Will Add $4.8 Bil. To Rx Sales In 2004, CIBC Estimates
The Medicare drug discount card will bring approximately $4.8 bil. in new revenue to the branded pharmaceutical industry in 2004, according to a CIBC analysis presented by Novartis VP-Business Development & Licensing Gary Cupit April 1 at an IIR conference in Philadelphia
Medicare Formularies Will Have Two Drugs Per Class; CMS To Track Atypicals
Medicare prescription drug plan formularies will have at least two drugs in each class, CMS Administrator-designate Mark McClellan says
Novartis Resumes Merger Search; Talks Up Schering, Ups Stake In Roche
Novartis is resuming its search for a merger partner, CEO Daniel Vasella indicated during the company's 2003 results conference Jan. 22 in Zurich